Rhinovirus (RV) is a single-stranded RNA virus from the Picornaviridae family responsible for the majority of common colds. Viral infections trigger the majority of asthma exacerbations (17, 22), and RV accounts for 60% of virus-induced exacerbations (17). RV is also an important trigger of chronic obstructive pulmonary disease exacerbations (28, 32) .
Rhinovirus (RV) is a single-stranded RNA virus from the Picornaviridae family responsible for the majority of common colds. Viral infections trigger the majority of asthma exacerbations (17, 22) , and RV accounts for 60% of virus-induced exacerbations (17) . RV is also an important trigger of chronic obstructive pulmonary disease exacerbations (28, 32) .
Numerous studies suggest a role for interleukin-8 (IL-8) in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD) exacerbations. IL-8, a CXC chemokine with the neutrophil attractant Glu-Leu-Arg (ELR) motif, and neutrophils are found in the nasal secretions and sputa of patients with RV-induced asthma exacerbations (8, 9, 12, 13, 26) . Further, the number of neutrophils correlates with the level of IL-8 (9, 26) . RV induces IL-8 expression in cultured airway epithelial cells (34, 38, 39) . Increased neutrophil and IL-8 levels are a feature of asthma (23, 24) and COPD exacerbations (1, 10, 27) . Together, these data suggest that RV may stimulate asthma and COPD exacerbations by inducing bronchial epithelial cell production of IL-8, leading to a neutrophilic inflammatory response.
We have recently shown that infection of human bronchial epithelial cells with RV serotype 39 (RV39) induces rapid phosphorylation of the p85 regulatory subunit of phosphatidylinositol 3 (PI 3)-kinase, as well as that of Akt, a downstream effector of PI 3-kinase (21) . RV39 also colocalized with CitAkt-PH, a fluorescent fusion protein containing the pleckstrin homology domain of Akt, indicating that PI(3,4,5)P 3 accumulates at the site of RV infection. Finally, inhibitions of PI 3-kinase activation with a chemical inhibitor and with dominant-negative p85␣ each inhibited RV39-induced IL-8 expression. However, the precise mechanism by which RV activates PI 3-kinase and the specific class IA PI 3-kinase catalytic subunit involved in RV-induced Akt phosphorylation were not determined.
Potential upstream activators of PI 3-kinase include the tyrosine kinase p60 Src and focal adhesion kinase, each of which regulates the remodeling of the actin cytoskeleton in response to cell adhesion and integrin clustering. Upon stimulation, Src translocates from the perinuclear region of the cell to peripheral sites of integrin clustering. Src binds to its substrates via its Src homology domains, which in turn interact with phosphotyrosine-containing or proline-rich sequences. Among its substrates are Src itself (autophosphorylation at tyrosine-416), focal adhesion kinase, and the p85 regulatory subunit of PI 3-kinase (15) . p85 PI 3-kinase, in turn, may form heterodimers with one of three class IA PI 3-kinase catalytic subunits (p110␣, p110␤, and p110␦). p110␣ and p110␤ are ubiquitously expressed, whereas p110␦ expression is largely restricted to cells of the immune system (4).
The human RVs include more than 100 serotypes, which are divided into two groups based on their cellular receptors. Intercellular adhesion molecule-1 (ICAM-1) is the airway epithelial cell receptor for major-subgroup RVs (e.g., RV14, -16, and -39). In endothelial cells, antibody-mediated clustering causes ICAM-1 to colocalize with Src in detergent-insoluble membrane domains, i.e., lipid rafts (35) . ICAM-1 cross-linking increases phosphorylation and activation of Src in endothelial cells (7, 37) . It has recently been shown that RVs infect human epithelial cells via ceramide-enriched membrane platforms (11) . We therefore hypothesized that the Src-mediated activation of PI 3-kinase and its downstream effector Akt is a critical event in the transduction of RV signaling.
MATERIALS AND METHODS
Cell culture. 16HBE14oϪ human bronchial epithelial cells originating from bronchial epithelial tissue transfected with pSVori-, containing the origin-defective simian virus genome (5), were provided by Steven White (University of Chicago). Cells were grown in minimum essential medium supplemented with 10% fetal bovine serum and 2 mM of L-glutamine.
Human primary airway epithelial cells obtained from the tracheal trimmings of donor lungs at the time of double lung transplantation were cultured in collagencoated plates with bronchial epithelial cell culture media (Cambrex, East Rutherford, NJ) as previously described (21, 30) . First-passage cells were either grown under submerged conditions or, for selected experiments, differentiated to a mucociliary phenotype by seeding on collagen-coated transwells. After growth to confluence, cells were shifted to an air-liquid interface and maintained in a 1:1 mixture of bronchial epithelial cell culture medium and Dulbecco's modified Eagle medium for 3 weeks. The resulting epithelium was pseudostratified with ciliated cells interspersed among mucus-secreting cells.
Rhinovirus. RV39 was obtained from American Type Culture Collection (Manassas, VA). Viral stocks were generated by infecting HeLa cells with RV until 80% of the cells were cytopathic. HeLa cells were serum deprived overnight, lysates were harvested, and cellular debris was pelleted by centrifugation (10,000 ϫ g for 30 min at 4°C). RV was concentrated and partially purified by centrifugation with a 100,000-molecular-weight-cutoff Centricon filter (2,000 rpm at 4°C for 8 h; Millipore, Billerica, MA) (25) . Similarly treated HeLa cell lysates from mock-infected cells served as controls (sham medium controls). RHINOVIRUS, Src, AND PI 3-KINASE 1187
Transfection of cells and measurement of IL-8 promoter activity. 16HBE14oϪ cells grown in six-well plates were transiently transfected with the Ϫ162/ϩ44 fragment of the human IL-8 promoter (3) and Renilla luciferase by use of Lipofectamine (Invitrogen, Carlsbad, CA). Selected cultures were cotransfected with cDNA encoding dominant-negative K296R/Y528F Src (20) . Other cells were cotransfected with 100 nM of Src small interfering RNA (siRNA), p110␤ PI 3-kinase, or nontargeting RNA control (Dharmacon, Lafayette, CO). The following day, the cells were shifted to serum-free media and infected with RV at a multiplicity of infection (MOI) of 1.0 for 1 h. Inoculum was replaced with fresh serum-free medium and incubated at 33°C for 24 h, and the cells were harvested for analysis. Luciferase activity was measured with a luminometer. Promoter activity was normalized for transfection efficiency by dividing luciferase light units by Renilla luciferase light units. Results were reported as increases (n-fold) over values for the empty vector/untreated control.
Measurement of IL-8 production. IL-8 production following RV39 infection was measured using Duoset enzyme-linked immunosorbent assay development kits purchased from R&D Systems (Minneapolis, MN). In selected cultures, cells were pretreated with dimethyl sulfoxide, PP2 {4-amino-5-(4-chlorophenyl)-7-(tbutyl)pyrazolo [3,4-d] pyrimidine} (16) , or PP3 {4-amino-7-phenylpyrazol [3,4-d] pyrimidine } (36) for 1 h prior to viral infection. PP2 and PP3 were obtained from Calbiochem (San Diego, CA). 16HBE14oϪ cells were incubated with virus (MOI of 1.0) for 1 h, the virus-containing media removed, and fresh media with serum and the indicated concentrations of inhibitors added for a further 48 h before IL-8 release was assessed. Primary mucociliary differentiated cells were apically infected with virus (50% tissue culture infectivity dose [TCID 50 ] of 5 ϫ 10 6 ), and fresh medium and inhibitors added for a further 24 h before IL-8 release into the basolateral medium was assessed.
Western blot analysis of cell lysates and immunoprecipitates. In selected experiments, 16HBE14oϪ cells were washed briefly in cold phosphate-buffered saline and incubated with homogenization buffer consisting of 50 mM Tris (pH 7.5), 100 mM NaCl, 50 mM NaF, 40 mM ␤-glycerophosphate, 2 mM EDTA, 200 M Na 3 VO 4 , and 1% Triton X-100 containing complete protease inhibitors (Roche Diagnostics, Indianapolis, IN). Cells were homogenized by passing through a 28-gauge needle and centrifuged. Supernatants were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis, proteins transferred to nitrocellulose, and membranes probed with either rabbit C-terminal anti-Src recognizing amino acids 400 to 422 (Upstate Biotechnology, Charlottesville, VA), rabbit anti-phospho-Ser 473 , rabbit anti-Akt (both from Cell Signaling, Beverly, MA), or rabbit anti-p110␤ PI 3-kinase (Epitomics, Burlingame, CA). Bound antibody was detected by secondary antibody conjugated to horseradish peroxidase, and the signal detected by chemiluminescence. In other experiments, cell lysates were immunoprecipitated with mouse monoclonal 4G10 anti-phosphotyrosine (2 g; Upstate Biotechnology). Immunoprecipitates were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to nitrocellulose, and probed with either rabbit anti-phospho-Tyr 416 Src (Cell Signaling) or mouse anti-Src (clone GD11 recognizing amino acids 82 to 169; Upstate Biotechnology). No bands were detected when isotype control antibodies were substituted for primary antibodies (not shown).
Immunofluorescent staining. To visualize RV39 internalization into 16HBE14oϪ and submerged primary airway epithelial cells, cells were plated on collagen-coated slides (Becton Dickinson Labware, Bedford, MA) and infected with virus at an MOI of between 10 and 100, or an equal volume of cell lysate from uninfected HeLa cells, for 10 min at 33°C. The cells were then washed extensively and fixed in 1% paraformaldehyde. Cells were permeabilized with 1% (vol/vol) Triton X-100 in phosphate-buffered saline, blocked, and incubated with either guinea pig anti-RV39 (American Type Culture Collection), rabbit antiphospho-Tyr 416 Src, mouse anti-Src (monoclonal GD11), rabbit anti-phosphoSer 473 Akt, rabbit anti-Akt, mouse or sheep anti-digoxigenin (Roche Diagnostics), rabbit anti-p85␣ PI 3-kinase, rabbit anti-p110␤ PI 3-kinase, or mouse anti-ceramide immunoglobulin M (Sigma Chemical, St. Louis, MO). After being incubated with the appropriate Alexa-Fluor-conjugated secondary antibody (Molecular Probes, Portland, OR), cells were mounted with ProLong Antifade reagent (Molecular Probes) and visualized by confocal fluorescent microscopy with a Zeiss LSM 510 confocal microscope mounted on a Zeiss Axiovert 100 M inverted microscope. Some experiments were performed with 16HBE14oϪ cells stably transfected with Cit-Akt-PH, a cDNA encoding a fusion protein of Citro- gen and the PI(3,4,5)P 3 -binding Akt pleckstrin homology domain (21) . Minimal staining was detected when isotype control antibodies were substituted for primary antibodies (not shown). RV39 labeling. In selected experiments, virus was labeled for immunoprecipitation and fluorescent microscopy using an N-hydroxysuccinimide derivative of digoxigenin, an amine-reactive form of this epitope tag (Roche Diagnostics). In a modification of described methods previously used to label RV with Alexa-Fluor dye (21), 0.4 ml of 0.1 M NaHCO 3 was added to a 0.1-ml aliquot of purified, concentrated virus to raise the pH to 8. Crosstide is a glycogen synthase kinase ␣/␤ fusion protein sequence (GRPRTSSFAEG) which is a substrate for Akt (6) . Samples were processed for autoradiography and immunoblotting using rabbit anti-phospho-Tyr 416 Src, mouse anti-Src (clone GD11), rabbit anti-phospho-Ser 473 , or rabbit anti-Akt. Reverse transcriptase PCR (RT-PCR). cDNA was generated using 0.2 to 0.5 g of RNA using Superscript reverse transcriptase (Invitrogen) and specific antisense first-strand primers for PI 3-kinase class IA␣ (5ЈCT TTT CAG TTC AAT GCA TGC), IA␤ (5ЈTTA AGA TCT GTA GTC TTT CC), or IB␥ (5ЈTTA GGC TGA ATG TTT CTC TGG) cDNA. Taq DNA polymerase (Invitrogen) and 2.5 M of specific primer were used.
To detect class I PI 3-kinases, we used 0.4 M of each primer and 10 ng of cDNA template in a reaction volume of 100 l for a total of 30 cycles. Specific PI 3-kinase primer sequences were as follows. For IA␣ (accession no. NM_006218), forward primer 5Ј TGGGATGTATTTGAAGCACC 3Ј and nested reverse primer 5Ј TTTCGCACCACCTCAATAAG 3Ј was used to produce a 474-bp product. For IA␤ (accession no. NM_006219), forward primer 5Ј GTTGCGCTTGATGGATTTACT 3Ј and nested reverse primer 5Ј TCACAA CACTGGCGGAACC 3Ј were expected to produce a 506-bp product. Finally, for IB␥ (accession no. NM_002649), forward primer 5Ј ATGCTGCACGACTT TACCC 3Ј and nested reverse primer 5Ј TGGGGCTTGGGGGTCTTCTG 3Ј were expected to produce a 490-bp product.
Data analysis. All experiments were performed a minimum of three times. 
RESULTS

Src is activated by RV infection and required for RV39-induced Akt activation.
We have recently shown that the infection of human bronchial epithelial cells with RV39 induces the rapid phosphorylation of the p85 regulatory subunit of PI 3-kinase (21) . To determine whether Src is involved in RVinduced PI 3-kinase activation, we examined the localization of RV39, Src, and PI 3-kinase in RV39-infected 16HBE14oϪ human bronchial epithelial cells by confocal fluorescence microscopy. We found a close association of RV, Src, and p85 PI 3-kinase (Fig. 1, upper panel) . There was also colocalization of RV, Src, and stably expressed Cit-Akt-PH, a marker of PI(3,4,5)P 3 -containing membranes (middle panel). Finally, RV and Cit-Akt-PH colocalized with p110␤, a catalytic subunit of PI 3-kinase (lower panel).
Compared to sham-infected cells, 16HBE14oϪ cells infected with RV39 also demonstrated colocalization of RV39 and phospho-Tyr 416 Src (Fig. 2, upper panel) . Colocalization was blocked when cells were preincubated with the Src family kinase inhibitor PP2 but not with its less potent analogue PP3. A similar pattern of colocalization was observed with RV and phospho-Ser 473 Akt (Fig. 2, lower panel) . Again, colocalization was demonstrated by preincubation with PP2 but not with PP3. The PI 3-kinase inhibitor LY294002 blocked virus internalization and colocalization of RV39 and phospho-Akt but did not block virus binding.
Infection of 16HBE14oϪ cells with RV39 (MOI of 1.0 for 10 min at 33°C) was also sufficient to increase Tyr 416 phosphorylation of a 60-kDa Src family kinase (Fig. 3A and B) . Immunoblots of cell extracts with the C-terminal anti-Src antibody showed the presence of Src. We were unable to detect Fyn, another Src family kinase with a molecular mass of approximately 60 kDa (not shown). Src phosphorylation was efficiently blocked by PP2 but not by PP3. RV39 infection also induced phosphorylation of Ser 473 Akt (Fig. 3C) . Akt phosphorylation was blocked by PP2 as well as the PI 3-kinase inhibitor LY294002.
Digoxigenin-labeled RV39 associates with an active complex of signaling molecules, including Src and Akt. To better study such RV39-protein complexes, an immunoprecipitable RV39 was developed using a chemically modified form of the virus similar to that used in our previous work (21) . An N-hydroxysuccinimide derivative of digoxigenin was used to tag the capsid surface, thereby providing a specific epitope for immunochemistry. The chemically modified form of RV39 retained infectivity identical to that of unmodified virus. We reasoned that immunoprecipitation with anti-digoxigenin would obtain a Triton-insoluble complex of RV39 bound to its receptor and associated signaling molecules. 16HBE14oϪ cells were infected with digoxigenin-labeled RV39 (MOI of 1.0) for 10 min. Cells were lysed in 1% Triton X-100 and centrifuged (10,000 ϫ g), and the supernatant was collected for immunoprecipitation with anti-digoxigenin. Immunoprecipitates were incubated with [␥-32 P]ATP and Crosstide, a glycogen synthase kinase ␣/␤ fusion protein sequence which is a substrate for Akt (6) . Cells exposed to RV39 demonstrated a Crosstide kinase activity in vitro (Fig. 4) . This kinase activity was not found when cells were exposed to an equimolar (based on digoxigenin) amount of labeled sham protein. Serine phosphorylation of Crosstide was confirmed by immunoblotting (not shown), and phosphorylation was blocked by PP2 but not by PP3. These data suggest that RV infection activates Akt in a Src-dependent manner.
Colocalization of RV, Src, and Akt with ceramide, a constituent of lipid rafts. It has recently been shown that RVs infect human epithelial cells via ceramide-enriched membrane platforms (11) . While nonionic detergents like Triton X-100 are sufficient to dissociate many membrane-associated complexes, initial experiments to biochemically enrich virus-associated rafts by sucrose density flotation met with unsatisfactory results because the virus tends to sediment in sucrose density gradients. We therefore colocalized RV and relevant signaling intermediates with ceramide. In this set of experiments, digoxigenin-labeled RV (MOI of 10) was used. Composite projection views show colocalization of RV39, ceramide, phospho-Tyr 416 Src, and phospho-Ser 473 Akt (Fig. 5A) . The association of RV39 with Src and Akt in ceramide-enriched lipid domains strongly suggests the formation of raft protein aggregates.
Digoxigenin-labeled RV39 colocalizes with Src in primary airway epithelial cells. We tested whether the colocalization of digoxigenin-labeled RV39 and Src occurs in primary human airway epithelial cells. Compared to sham-infected cells, cells infected with RV39 showed colocalization of RV and Src, as recognized by the GD11 antibody (Fig. 5B) . A z-axis section more clearly demonstrates the three-dimensional arrangement of RV and Src, with colocalization occurring just below the cell surface. Colocalization of RV39 and Src was blocked by PP2 but not by PP3.
Src kinase activity is required for the IL-8 response to RV39. We have recently shown that infection of human bronchial epithelial cells with RV39 induces rapid activation of PI 3-kinase and phosphorylation of the PI 3-kinase p85␣ regulatory subunit (21) . Since Src is associated with focal adhesion complexes and phosphorylates p85 (15), we tested the dependence of IL-8 production induced by RV39 on Src kinase activation. Src siRNA specifically reduced Src protein expression (Fig.  6A) . In 16HBE14oϪ human bronchial epithelial cells, expression of the dominant-negative K296R/Y528F Src or Src siRNA or treatment with the Src family-specific kinase inhibitor PP2 (0.1 to 1 M) significantly inhibited RV39-induced transcription from the IL-8 promoter (Fig. 6B) . PP2 also attenuated IL-8 release from primary mucociliary differentiated airway epithelial cells infected with RV39 (Fig. 6C) . PP3 (1 M), an inactive analogue of PP2, did not significantly inhibit IL-8 release. Together, these findings suggest that Src is required for RV-stimulated IL-8 expression.
p110␤ PI 3-kinase is required for RV39-induced IL-8 expression. Using RT-PCR, we confirmed that p110␤ is present in airway epithelial cells (Fig. 7A) . Transient transfection of 16HBE14oϪ human bronchial epithelial cells with siRNA against p110␤ significantly inhibited p110␤ protein expression (Fig. 7A ) and RV39-induced transcription from the IL-8 promoter (Fig. 7B) , demonstrating that p110␤ is required for the response.
DISCUSSION
We have recently shown that infection of human airway epithelial cells with RV39 induces rapid activation of PI 3-kinase and phosphorylation of Akt. (21) . PI 3-kinase activation was accompanied by phosphorylation of the PI 3-kinase p85 (35) as well as Src phosphorylation and activation (7, 37) . Src/PI 3-kinase signaling has been noted to be activated in the context of viral infection twice previously. Engagement of the B lymphocyte Epstein-Barr virus receptor activates PI 3-kinase via Src (2). Expression of human herpesvirus 8 envelope glycoprotein gB induces Src/PI 3-kinase signaling in human foreskin fibroblasts (33) . We now extend this mode of entry to RV-infected human bronchial epithelial cells. The data shown here demonstrate that activation of a Src/p110␤ PI 3-kinase/ Akt pathway occurs coincident with the binding of RV into ceramide-enriched lipid domains as a prelude to internalization.
Expression of dominant-negative K296R/Y528F Src and Src siRNA, as well as pretreatment with a Src family kinase chemical inhibitor, each significantly attenuated RV39-induced IL-8 expression, demonstrating that Src is required for maximal RV-induced IL-8 expression. However, IL-8 expression was not completely eliminated, suggesting that other pathways are also required. Consistent with this, we have found that Tolllike receptor-3, a receptor for double-stranded RNA, is also required for RV-induced chemokine expression (31), as it is for respiratory syncytial virus and influenza virus, two other positive-strand RNA viruses (14, 29) .
Confocal micrographs showed that while RV39 infection induces Tyr 416 phosphorylation of Src, only a fraction of phosphoprotein colocalizes with RV. Lipid-lipid interactions involving amino-terminal acyl groups on Src family kinases, for example, palmitoylation, are the primary mechanism for membrane localization, particularly localization to membrane microdomains or lipid rafts (18) . The exclusion of a Src fraction from rafts implies that it may not encounter substrates needed for localization to lipid rafts and that this Src fraction may be performing functions distinct from those of raft-localized Src. Similarly, Ser 473 Akt phosphorylation was not confined to areas of colocalization with RV, suggesting diffusion of the class IA PI 3-kinase product PI(3,4,5)P 3 outside the raft area. These data are consistent with our previous data indicating membrane and cytoplasmic localization of the pleckstrin homology domain of Akt following RV infection (21) .
As in a previous study (11), we did not biochemically enrich RV-associated rafts by sucrose density flotation, as the virus tended to sediment in sucrose density gradients. Interestingly, rafts not associated with RV contained inactive/closed Tyr 527 -phosphorylated Src (19) (not shown). However, the association of RV, Src, Akt, and ceramide, which brings about the coalescence of microscopic rafts into large-membrane macrodomains, strongly suggests that RV initiates the formation of Srcand Akt-containing membrane platforms. Src may therefore represent a cellular target for intervention against RV-associated respiratory disease.
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